These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 12906331)

  • 1. Preparation and characterization of glassy celecoxib.
    Paradkar AR; Chauhan B; Yamamura S; Pawar AP
    Drug Dev Ind Pharm; 2003 Aug; 29(7):739-44. PubMed ID: 12906331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of spray-dried co-precipitate of amorphous celecoxib containing storage and compression stabilizers.
    Dhumal RS; Shimpi SL; Paradkar AR
    Acta Pharm; 2007 Sep; 57(3):287-300. PubMed ID: 17878109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physicochemical characterization and in vitro dissolution behaviour of celecoxib-beta-cyclodextrin inclusion complexes.
    Sinha VR; Anitha R; Ghosh S; Amita ; Kumria R; Bhinge JR; Kumar M
    Acta Pharm; 2007 Mar; 57(1):47-60. PubMed ID: 19839406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of a novel polymorphic form of celecoxib.
    Lu GW; Hawley M; Smith M; Geiger BM; Pfund W
    J Pharm Sci; 2006 Feb; 95(2):305-17. PubMed ID: 16369929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spherical crystallization of celecoxib.
    Paradkar AR; Pawar AP; Chordiya JK; Patil VB; Ketkar AR
    Drug Dev Ind Pharm; 2002 Nov; 28(10):1213-20. PubMed ID: 12476867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined Effect of the Preparation Method and Compression on the Physical Stability and Dissolution Behavior of Melt-Quenched Amorphous Celecoxib.
    Be Rziņš KR; Fraser-Miller SJ; Di R; Liu J; Peltonen L; Strachan CJ; Rades T; Gordon KC
    Mol Pharm; 2021 Mar; 18(3):1408-1418. PubMed ID: 33586988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Promising dissolution enhancement effect of soluplus on crystallized celecoxib obtained through antisolvent precipitation and high pressure homogenization techniques.
    Homayouni A; Sadeghi F; Varshosaz J; Afrasiabi Garekani H; Nokhodchi A
    Colloids Surf B Biointerfaces; 2014 Oct; 122():591-600. PubMed ID: 25124835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Study on mechanism for amorphous drug stabilization using gelucire 50/13.
    Shimpi SL; Mahadik KR; Paradkar AR
    Chem Pharm Bull (Tokyo); 2009 Sep; 57(9):937-42. PubMed ID: 19721253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spherical crystals of celecoxib to improve solubility, dissolution rate and micromeritic properties.
    Gupta VR; Mutalik S; Patel MM; Jani GK
    Acta Pharm; 2007 Jun; 57(2):173-84. PubMed ID: 17507314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism of drug release from polymethacrylate-based extrudates and milled strands prepared by hot-melt extrusion.
    Albers J; Alles R; Matthée K; Knop K; Nahrup JS; Kleinebudde P
    Eur J Pharm Biopharm; 2009 Feb; 71(2):387-94. PubMed ID: 18951978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physicochemical characterization and drug-release properties of celecoxib hot-melt extruded glass solutions.
    Andrews GP; Abu-Diak O; Kusmanto F; Hornsby P; Hui Z; Jones DS
    J Pharm Pharmacol; 2010 Nov; 62(11):1580-90. PubMed ID: 21072971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design and evaluation of celecoxib porous particles using melt sonocrystallization.
    Paradkar A; Maheshwari M; Kamble R; Grimsey I; York P
    Pharm Res; 2006 Jun; 23(6):1395-400. PubMed ID: 16741659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anomalous dissolution behavior of celecoxib in PVP/Isomalt solid dispersions prepared using spray drier.
    Ghanavati R; Taheri A; Homayouni A
    Mater Sci Eng C Mater Biol Appl; 2017 Mar; 72():501-511. PubMed ID: 28024614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation of an amorphous sodium furosemide salt improves solubility and dissolution rate and leads to a faster Tmax after oral dosing to rats.
    Nielsen LH; Gordon S; Holm R; Selen A; Rades T; Müllertz A
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):942-51. PubMed ID: 24075980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular Factors Governing the Liquid and Glassy States Recrystallization of Celecoxib in Binary Mixtures with Excipients of Different Molecular Weights.
    Grzybowska K; Chmiel K; Knapik-Kowalczuk J; Grzybowski A; Jurkiewicz K; Paluch M
    Mol Pharm; 2017 Apr; 14(4):1154-1168. PubMed ID: 28241116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physico-chemical characterization and stability study of glassy simvastatin.
    Ambike AA; Mahadik KR; Paradkar A
    Drug Dev Ind Pharm; 2005 Oct; 31(9):895-9. PubMed ID: 16306001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparing various techniques to produce micro/nanoparticles for enhancing the dissolution of celecoxib containing PVP.
    Homayouni A; Sadeghi F; Varshosaz J; Garekani HA; Nokhodchi A
    Eur J Pharm Biopharm; 2014 Sep; 88(1):261-74. PubMed ID: 24952357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigation of atypical dissolution behavior of an encapsulated amorphous solid dispersion.
    Puri V; Dantuluri AK; Bansal AK
    J Pharm Sci; 2011 Jun; 100(6):2460-8. PubMed ID: 21246560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enthalpy relaxation studies of celecoxib amorphous mixtures.
    Kakumanu VK; Bansal AK
    Pharm Res; 2002 Dec; 19(12):1873-8. PubMed ID: 12523668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of surfactants on the crystal growth of amorphous celecoxib.
    Mosquera-Giraldo LI; Trasi NS; Taylor LS
    Int J Pharm; 2014 Jan; 461(1-2):251-7. PubMed ID: 24333451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.